title: Endosomes: guardians against [Ru(Phen)3]2+ photo-action in endothelial cells during in vivo pO2 detection?
abstract: Phototoxicity is a side-effect of in vitro and in vivo oxygen partial pressure (pO2) detection by luminescence lifetime measurement methods. Dichlorotris(1,10-phenanthroline)-ruthenium(ii) hydrate ([Ru(Phen)3]2+) is a water soluble pO2 probe associated with low phototoxicity, which we investigated in vivo in the chick's chorioallantoic membrane (CAM) after intravenous or topical administration and in vitro in normal human coronary artery endothelial cells (HCAEC). In vivo, the level of intravenously injected [Ru(Phen)3]2+ decreases within several minutes, whereas the maximum of its biodistribution is observed during the first 2 h after topical application. Both routes are followed by convergence to almost identical "intra/extra-vascular" levels of [Ru(Phen)3]2+. In vitro, we observed that [Ru(Phen)3]2+ enters cells via endocytosis and is then redistributed. None of the studied conditions induced modification of lysosomal or mitochondrial membranes without illumination. No nuclear accumulation was observed. Without illumination [Ru(Phen)3]2+ induces changes in endoplasmic reticulum (ER)-to-Golgi transport. The phototoxic effect of [Ru(Phen)3]2+ leads to more marked ultrastructural changes than administration of [Ru(Phen)3]2+ only (in the dark). These could lead to disruption of Ca2+ homeostasis accompanied by mitochondrial changes or to changes in secretory pathways. In conclusion, we have demonstrated that the intravenous injection of [Ru(Phen)3]2+ into the CAM model mostly leads to extracellular localization of [Ru(Phen)3]2+, while its topical application induces intracellular localization. We have shown in vivo that [Ru(Phen)3]2+ induces minimal photo-damage after illumination with light doses larger by two orders of magnitude than those used for pO2 measurements. This low phototoxicity is due to the fact that [Ru(Phen)3]2+ enters endothelial cells via endocytosis and is then redistributed towards peroxisomes and other endosomal and secretory vesicles before it is eliminated via exocytosis. Cellular response to [Ru(Phen)3]2+, survival or death, depends on its intracellular concentration and oxidation-reduction properties.
authors.affiliation: Center for Interdisciplinary Biosciences, Faculty of Sciences, University of PJ Safarik in Kosice, Jesenna 5, 041 54 Kosice, Slovakia. veronika.huntosova@upjs.sk.
authors.forename: Veronika
authors.initials: V
authors.lastname: Huntosova
authors.forename: Katarina
authors.initials: K
authors.lastname: Stroffekova
authors.forename: Georges
authors.initials: G
authors.lastname: Wagnieres
authors.forename: Marta
authors.initials: M
authors.lastname: Novotova
authors.forename: Zuzana
authors.initials: Z
authors.lastname: Nichtova
authors.forename: Pavol
authors.initials: P
authors.lastname: Miskovsky
mesh_terms: D011992:Endosomes / Q000378:metabolism*; D042783:Endothelial Cells / Q000166:cytology / Q000187:drug effects* / Q000528:radiation effects*; D006801:Humans; D042541:Intracellular Space / Q000378:metabolism; D008163:Luminescent Measurements; D009942:Organometallic Compounds / Q000737:chemistry / Q000494:pharmacology*; D010100:Oxygen / Q000378:metabolism*; D010313:Partial Pressure; D010618:Phenanthrolines / Q000737:chemistry / Q000494:pharmacology*
chemical_list: D009942:Organometallic Compounds; D010618:Phenanthrolines; C034282:tris-(1,10-phenanthroline)ruthenium; D010100:Oxygen